Back
PT Bank Central Asia Tbk Vs. Corcept Therapeutics Industry Stock Comparison
Buy
51
PBCRF
PT Bank Central Asia Tbk
Last Price:
$0.52
Seasonality Move:
6.26%
Buy
67
CORT
Corcept Therapeutics
Last Price:
$70.57
Seasonality Move:
10.06%
Buy
51
PT Bank Central Asia Tbk (PBCRF)
is a Buy
Is PT Bank Central Asia Tbk a Buy, Sell or Hold?
-
The current PT Bank Central Asia Tbk [PBCRF] share price is $0.52. The Score for PBCRF is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
PBCRF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $72.14. The Score for CORT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PBCRF Stock Price Chart
What is PT Bank Central Asia Tbk's stock price today?
-
The PT Bank Central Asia Tbk share price today is $0.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBCRF is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $72.14The current trend is moderately bullish and CORT is experiencing slight buying pressure.
PBCRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 61.67 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.52) | Buy |
Bollinger Bands (100): | (0.48 - 0.58) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.33 | Buy |
Relative Strength Index (14 RSI): | 53.36 | Buy |
Chaikin Money Flow: | 460045 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.64 - 73.18) | Buy |
Bollinger Bands (100): | (52.96 - 73.02) | Buy |
PBCRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.52 | Buy |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.5 | Buy |
200-day SMA: | 0.6 | Sell |
8-day EMA: | 0.52 | Buy |
20-day EMA: | 0.5 | Buy |
50-day EMA: | 0.51 | Buy |
200-day EMA: | 0.56 | Sell |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.64 | Buy |
20-day SMA: | 69.67 | Buy |
50-day SMA: | 66.57 | Buy |
200-day SMA: | 53.74 | Buy |
8-day EMA: | 71.32 | Buy |
20-day EMA: | 69.15 | Buy |
50-day EMA: | 54.49 | Buy |
200-day EMA: | 21.72 | Buy |
PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
PT Bank Central Asia Tbk Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |